Kirk Gallion of Octagon Research Solutions, Inc., Recognized by the PharmaVOICE 100
Octagon President honored as one of the most inspiring people in the life sciences industry
Wayne, PA, August 01, 2007 --(PR.com)-- CEO & Chairman Jim Walker of Octagon Research Solutions, Inc., a pioneer and leader in the electronic transformation of clinical R&D in the life sciences industry, announced today that Kirk Gallion, president and co-founder, has been recognized by the PharmaVOICE 100 as one of the most inspiring people in the life sciences industry.
The third annual PharmaVOICE 100 list is composed of those individuals who PharmaVOICE’s readers selected because of their ability make an impact on the life sciences industry through leadership, research and development, technology, creativity, marketing, and strategy. These individuals were chosen based on the number of nominations submitted by the readers and the write-ups that accompanied these nominations.
Jim Walker, chairman and CEO of Octagon, commented, “Kirk’s innate leadership skills and high standards are evident in his zero defect mentality that is pervasive throughout Octagon’s technology and products. His commitment to the development of new and enhanced technologies is the driving force behind our break-through process management technology, ViewPoint®. This recognition is well-deserved.” Mr. Walker noted, “This is the third consecutive year that a member of our executive team has been selected as part of the PharmaVOICE 100 which reflects Octagon’s commitment to recruiting and retaining respected thought leaders and top talent in the industry.”
“It is an honor to be recognized in the company of such well-known and accomplished individuals,” commented Gallion. “We are moving an entire industry in a new direction by challenging traditional approaches to drug development. Working in an entrepreneurial environment with a great team of technology professionals dedicated to improving clinical R&D processes has been very rewarding in itself. Recognition in the 2007 PharmaVOICE 100 adds to our momentum and is a great motivator.”
The PharmaVOICE 100 included Octagon’s Nancy Smerkanich, vice president, regulatory affairs and Dave Evans, chief information officer, in 2005 and 2006 respectively. Kirk Gallion, as well as the other 2007 honorees, will be showcased in the July/August issue of PharmaVOICE.
About Octagon Research Solutions, Inc.
Octagon is a pioneer and leading process-centric solutions provider that offers a suite of regulatory, clinical, process, and IT solutions to the life sciences industry. Octagon synchronizes processes and increases automation to reduce island-to-island inefficiencies within the clinical research and development process. They leverage the power of electronic submissions through deep domain knowledge, cross-functional electronic submission expertise, a holistic process approach, and integrated solutions. Octagon is headquartered in Wayne, PA, with European headquarters in Berkhamsted, UK. For more information please visit octagonresearch.com.
###
The third annual PharmaVOICE 100 list is composed of those individuals who PharmaVOICE’s readers selected because of their ability make an impact on the life sciences industry through leadership, research and development, technology, creativity, marketing, and strategy. These individuals were chosen based on the number of nominations submitted by the readers and the write-ups that accompanied these nominations.
Jim Walker, chairman and CEO of Octagon, commented, “Kirk’s innate leadership skills and high standards are evident in his zero defect mentality that is pervasive throughout Octagon’s technology and products. His commitment to the development of new and enhanced technologies is the driving force behind our break-through process management technology, ViewPoint®. This recognition is well-deserved.” Mr. Walker noted, “This is the third consecutive year that a member of our executive team has been selected as part of the PharmaVOICE 100 which reflects Octagon’s commitment to recruiting and retaining respected thought leaders and top talent in the industry.”
“It is an honor to be recognized in the company of such well-known and accomplished individuals,” commented Gallion. “We are moving an entire industry in a new direction by challenging traditional approaches to drug development. Working in an entrepreneurial environment with a great team of technology professionals dedicated to improving clinical R&D processes has been very rewarding in itself. Recognition in the 2007 PharmaVOICE 100 adds to our momentum and is a great motivator.”
The PharmaVOICE 100 included Octagon’s Nancy Smerkanich, vice president, regulatory affairs and Dave Evans, chief information officer, in 2005 and 2006 respectively. Kirk Gallion, as well as the other 2007 honorees, will be showcased in the July/August issue of PharmaVOICE.
About Octagon Research Solutions, Inc.
Octagon is a pioneer and leading process-centric solutions provider that offers a suite of regulatory, clinical, process, and IT solutions to the life sciences industry. Octagon synchronizes processes and increases automation to reduce island-to-island inefficiencies within the clinical research and development process. They leverage the power of electronic submissions through deep domain knowledge, cross-functional electronic submission expertise, a holistic process approach, and integrated solutions. Octagon is headquartered in Wayne, PA, with European headquarters in Berkhamsted, UK. For more information please visit octagonresearch.com.
###
Contact
Octagon Research Solutions, Inc.
Lisa Donato
610 535 6500
www.octagonresearch.com
Lisa Donato
610 535 6500
www.octagonresearch.com
Contact
Categories